744 related articles for article (PubMed ID: 2981242)
1. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
2. The role of endogenous opioid peptides in the control of androgen levels in the male nonhuman primate.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Androl; 1984; 5(5):339-43. PubMed ID: 6094409
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
Leadem CA; Kalra SP
Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
[TBL] [Abstract][Full Text] [Related]
4. Possible delta receptor mediation of the effect of beta-endorphin on luteinizing hormone (LH) release, but not on prolactin (PRL) release, in the ovariectomized rat.
Wiesner JB; Koenig JI; Krulich L; Moss RL
Endocrinology; 1985 Jan; 116(1):475-7. PubMed ID: 2981076
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system peptide and amino acid modulation of luteinizing hormone and prolactin secretion in the pig.
Kraeling RR; Barb CR; Leshin LS; Rampacek GB
J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):79-103. PubMed ID: 1343978
[TBL] [Abstract][Full Text] [Related]
6. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
7. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
8. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
Van Vugt DA; Baby N; Stewart M; Reid RL
Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
[TBL] [Abstract][Full Text] [Related]
9. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
10. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.
Petraglia F; Vale W; Rivier C
Endocrinology; 1986 Dec; 119(6):2445-50. PubMed ID: 2877862
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
12. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
Gold MS; Redmond DE; Donabedian RK
Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
Gindoff PR; Ferin M
Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
[TBL] [Abstract][Full Text] [Related]
14. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
16. Gonadal steroid modulation of brain opioid systems.
Limonta P; Maggi R; Dondi D; Martini L; Piva F
J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey.
VanVugt DA; Webb MY; Reid RL
Neuroendocrinology; 1989 Mar; 49(3):275-80. PubMed ID: 2716954
[TBL] [Abstract][Full Text] [Related]
18. The prepubertal hiatus in gonadotropin secretion in the male rhesus monkey (Macaca mulatta) does not appear to involve endogenous opioid peptide restraint of hypothalamic gonadotropin-releasing hormone release.
Medhamurthy R; Gay VL; Plant TM
Endocrinology; 1990 Feb; 126(2):1036-42. PubMed ID: 2105200
[TBL] [Abstract][Full Text] [Related]
19. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
Reid RL; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
[TBL] [Abstract][Full Text] [Related]
20. Evidence for endogenous opioid modulation of serum luteinizing hormone and prolactin in the steer.
Peck DD; Thompson FN; Stuedemann JA; Leshin LS; Kiser TE
J Anim Sci; 1988 Dec; 66(12):3197-201. PubMed ID: 3230079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
